Improve walking using auditory cueing

Trial ID
NCT06142448
Official Title
Unravelling the Neural Mechanisms Underlying Compensation Strategies for Gait Impairments in Parkinson's Disease: a Transnational, Multimodal Approach
Goal
Improve walking using auditory cueing
Phase
NA
Status
RECRUITING
Sponsor
Radboud University Medical Center
Study Type
INTERVENTIONAL
Enrollment
384 participants
Conditions
Parkinson Disease
Interventions
Cueing app

Plain-Language Summary

Goal: Learn how the brain uses external compensation strategies to improve walking problems in Parkinson's, like slow steps, unstable rhythm, and freezing, so clinicians can target the right neural pathways. Approach: Participants use a cueing app that delivers timed external signals, usually rhythmic auditory beats, to guide step timing and spacing, engaging attention and alternative motor circuits to bypass impaired automatic gait control. Eligibility: Adults 18 and older with idiopathic Parkinson's who can walk at least three minutes unaided (a cane is allowed), who have not used daily compensation strategies in the past month, and who do not have deep brain stimulation, severe hearing loss, or significant cognitive impairment (MMSE <21).

Locations

  • Radboudumc, Nijmegen, Netherlands

Frequently Asked Questions

What is this trial testing?
This trial is studying Cueing app. Goal: Learn how the brain uses external compensation strategies to improve walking problems in Parkinson's, like slow steps, unstable rhythm, and freezing, so clinicians can target the right neural pathways. Approach: Participants use a cueing app that delivers timed external signals, usually rhythmic auditory beats, to guide step timing and spacing, engaging attention and alternative motor circuits to bypass impaired automatic gait control. Eligibility: Adults 18 and older with idiopathic Parkinson's who can walk at least three minutes unaided (a cane is allowed), who have not used daily compensation strategies in the past month, and who do not have deep brain stimulation, severe hearing loss, or significant cognitive impairment (MMSE <21).
Who can participate?
Participants must be at least 18 Years.
Where is this trial located?
This trial is recruiting at 1 location.
Does it cost anything to join?
No. There is no cost to participate. Study-related care and treatment are provided at no charge.
How long does the trial last?
This trial is estimated to last approximately 3 years.

View on ClinicalTrials.gov